Anzeige
Mehr »
Login
Sonntag, 28.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Nurexone Biologic: Jetzt diese wirklich einzigartige Chance ergreifen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
142 Leser
Artikel bewerten:
(0)

Allergy & Asthma Network Announces Free Webinar on Allergic Reactions to Insect Stings

VIENNA, Va., July 10, 2014 /PRNewswire-USNewswire/ --Allergy & Asthma Network, a leading nonprofit patient education organization, invites you to join its "2014 Venom Allergy 101" webinar on July 24, 2014, at 7 p.m. EST. This webinar is perfect for the summer as stinging insects abound in outdoor areas. Learn how to protect yourself from stings as well as how to respond and treat a potential allergic reaction.

Venom allergies are caused by five types of insects: honey bees, hornets, yellow jackets, paper wasps and fire ants. According to the American College of Allergy, Asthma & Immunology, the percentage of people affected by insect sting allergies is increasing - it now affects up to 5 percent of the U.S. population.

During this 1-hour webinar, participants will learn about venom allergy prevalence, diagnosis, treatment and immunotherapy from David Lang, MD, board-certified allergist at the Cleveland Clinic.

"Even if you've had mild allergic reactions to insect stings in the past, there is always the chance thatfuture reactions canprogress intomore severe and possibly fatal anaphylactic reactions. It's critical that people recognize an anaphylactic reaction and use the proper medicine, epinephrine, to treat it. We are pleased that this webinar is available to the public and encourage people in our community to watch it," says Erika Gonzalez-Reyes, MD, board-certified allergist and Anaphylaxis Community Expert (ACE) volunteer from San Antonio, TX.

To participate in the webinar, please register at https://venomallergywebinar.eventbrite.com. The "2014 Venom Allergies 101" webinar is sponsored by Mylan Specialty L.P.

About Allergy & Asthma Network
Allergy & Asthma Network is the leading national nonprofit organization dedicated to ending needless death and suffering due to asthma, allergies and related conditions. The Network specializes in sharing family-friendly, medically accurate information through its award-winning publication Allergy & Asthma Today magazine, E-newsletter, website at http://www.aanma.org and numerous community outreach programs. Follow Allergy & Asthma Network on Facebook at facebook.com/AANMA and on Twitter at twitter.com/AANMA. Join Allergy & Asthma Network at http://www.aanma.org/join.

About ACE
The Anaphylaxis Community Experts (ACE) program is developed by Allergy & Asthma Network in partnership with the American College of Allergy, Asthma & Immunology (ACAAI), National Association of School Nurses and American School Health Association and sponsored by Mylan Specialty L.P. The program goal is to save lives through showing parents, school staff, emergency responders, and others how to recognize and respond immediately to anaphylaxis symptoms.

To learn more about the ACE program or request an ACE team presentation, email Brenda Silvia-Torma, ACE Program Manager at ace@aanma.org.

Contact:
Gary Fitzgerald
Allergy & Asthma Network
703-641-9595
gfitzgerald@aanma.org

SOURCE Allergy & Asthma Network

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2014 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.